Cigna Debt Issuance Proceeds decreased by 100.0% to $0.00 in Q4 2025 compared to the prior quarter.
An increase indicates successful access to capital markets for expansion or refinancing, while a decrease may suggest a focus on deleveraging or limited market access.
This metric tracks the total cash proceeds received from the issuance of long-term or short-term debt instruments. It re...
Large-cap companies frequently issue debt to optimize their cost of capital; peers monitor this to maintain investment-grade credit ratings.
debt_issuance| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q1 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $1.49B | $4.46B | $0.00 | $0.00 | $4.46B | $0.00 |
| QoQ Change | — | — | — | — | — | +199.3% | -100.0% | — | — | -100.0% |
| YoY Change | — | — | — | — | — | +199.3% | -100.0% | — | — | — |